WO2000038590A1 - Endoluminal stent - Google Patents
Endoluminal stent Download PDFInfo
- Publication number
- WO2000038590A1 WO2000038590A1 PCT/GB1999/004388 GB9904388W WO0038590A1 WO 2000038590 A1 WO2000038590 A1 WO 2000038590A1 GB 9904388 W GB9904388 W GB 9904388W WO 0038590 A1 WO0038590 A1 WO 0038590A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- core
- agents
- therapeutic agent
- lining
- endoluminal stent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
Definitions
- This invention relates to an improved construction of an endoluminal stent, such devices being used for example, to hold open blood vessels dilated by angioplasty, particularly blood vessels having a higher flow, such as the iliac arteries.
- endoluminal stent devices may be deployed elsewhere in the mammalian body (usually human) for example, along the length of the gut, the bile duct, the pancreatic duct or the urethra.
- Such devices usually comprise a tubular cage structure which is inserted collapsed into a blood vessel, or other tubular structure, and thereafter expanded using a balloon catheter or using the self-expanding properties of the alloy from which it is constructed, for example.
- Stent devices having an open lattice structure are used normally with the lattices providing for expansion of the stent after insertion.
- a disadvantage of such constructions, however, is that the interstices allow for smooth muscle cell growth to invade through the stent, thus once again blocking the lumen.
- One of the objects of this invention is to provide an endoluminal stent giving an improved blood flow and longer in situ therapeutic life.
- a further and preferred object of this invention is to provide a stent which is capable of delivering a therapeutic agent or agents over a period of time.
- an agent might be directed specifically at preventing the growth of smooth
- an endoluminal stent having a rigid or semi-rigid, preferably metallic,
- outer expandable preferably a porous or semi-porous, absorbent or fabric
- the linings, within and without, may or may not in themselves be covered
- bio-polymer carrier medium for example, collagen or gelatin and may be a
- an endoluminal stent comprising a preferably metallic self-supporting core with a plurality of regularly or irregularly extending slits or cuts running longitudinally along the core whereby the core may be expanded such that the slits open up to define the interstices with preferably an outer covering of an expandable material provided over the core and an internal expandable lining within the core, one or other or both of said coverings or linings being capable of both part-retaining and permitting diffusion of a therapeutic agent or agents held therein retained in the slits or interstices of the core, preferably incorporated or held within a biologically inert, biodegradable bio-polymer.
- the construction according to a first aspect of this invention thus provides for a covering and lining of a fabric material to be provided preferably on both external and internal surfaces of the stent, thus preventing external intrusion through the interstices of the rigid core as well as improving blood flow through the internal passage formed by the core.
- the therapeutic agent or agents may be carried, for example, by means of an impregnated collagen sponge or gel film or the like which may form an additional layer preferably enclosed on both sides by the coverings or linings.
- Other carriers may be used to hold the therapeutic agent or agents.
- Figure 1 shows in side elevation a stent with a part of the core and the outer covering removed for clarity
- Figure 2 shows an end elevation of the stent shown in Figure 1.
- the endoluminal stent of this invention includes a core 1 of stainless steel or an alloy such as nitinol which has an expandable capability. The construction is such that after assisted or self-expansion, the core is sufficiently rigid to support the vessel into which it is inserted.
- the core 1 is shown here in a partially expanded state. Interstices or the spaces between the metal parts are here referenced 1a.
- the core 1 has an outer covering 2 of a material such as Dacron or PTFE. Where Dacron material is used, this may be coated on a single surface or both surfaces with an agent or agents such as collagen or gelatin, in order to decrease the material porosity and enhance incorporation into surrounding tissues. This coating in itself may in turn be bonded with or incorporate a therapeutic agent or agents such as Heparin or an antibiotic.
- a material such as Dacron or PTFE.
- the core 1 includes a lining 3 of a similar or other material to the outer covering layer. Where Dacron material is used, this may be coated on a single surface or both surfaces with an agent or agents such as collagen or gelatin, in order to decrease the material porosity and enhance incorporation
- This coating in itself may in turn be bonded with or
- a therapeutic agent or agents such as Heparin or an antibiotic.
- the outer covering layer may be connected with the inner lining layer at
- the covering and lining may also be any other means.
- the covering and lining may also be any other means.
- therapeutic agent or agents may be diffused over a period of time into the
- the material used to cover the metallic stent core should have certain properties
- outer covering 2 and lining 3 may be bonded by
- the bonding agent or agents itself may incorporate a required therapeutic agents.
- This invention also contemplates a method of treatment of the body and particularly any blood vessel or other tubular or elongate structure, for example a urethra or bile duct or other part of the gastro-intestine tract or uro-genital tract, which comprises the insertion of an endoluminal stent substantially as hereinbefore disclosed with the stent device incorporating means for retention of a therapeutic agent or agents, the agent or agents being effective on an ongoing basis following insertion of the stent.
- an endoluminal stent substantially as described and disclosed herein for the purpose of administering a therapeutic agent or agents to the flow of blood through a vessel in a mammalian body or other tubular or elongate structure, for example a urethra or bile duct or other part of the gastro-intestine tract or uro- genital tract.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU18790/00A AU1879000A (en) | 1998-12-23 | 1999-12-23 | Endoluminal stent |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9828592.7 | 1998-12-23 | ||
GBGB9828592.7A GB9828592D0 (en) | 1998-12-23 | 1998-12-23 | Endoluminal stent |
GB9912729.2 | 1999-06-01 | ||
GBGB9912729.2A GB9912729D0 (en) | 1998-12-23 | 1999-06-01 | Endoluminal stent |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000038590A1 true WO2000038590A1 (en) | 2000-07-06 |
Family
ID=26314918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1999/004388 WO2000038590A1 (en) | 1998-12-23 | 1999-12-23 | Endoluminal stent |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1879000A (en) |
GB (1) | GB2346559A (en) |
WO (1) | WO2000038590A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001021102A1 (en) * | 1999-09-23 | 2001-03-29 | Edwards Lifesciences Corporation | Double layer intraluminal graft |
WO2002091956A1 (en) * | 2001-05-16 | 2002-11-21 | Dias Maues, Christiane | Stent comprising a drug release coating thereon and delivering system thereof |
WO2002100473A1 (en) * | 2001-06-08 | 2002-12-19 | Graeme Cocks | Stent and delivery catheter |
US6503556B2 (en) | 2000-12-28 | 2003-01-07 | Advanced Cardiovascular Systems, Inc. | Methods of forming a coating for a prosthesis |
DE10135275A1 (en) * | 2001-07-13 | 2003-01-30 | Jotec Gmbh | Implant and process for its manufacture |
US6540776B2 (en) | 2000-12-28 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Sheath for a prosthesis and methods of forming the same |
WO2003090810A1 (en) * | 2002-04-26 | 2003-11-06 | Medtronic Vascular, Inc. | Overlapping coated stents |
WO2004019821A1 (en) * | 2002-08-28 | 2004-03-11 | Boston Scientific Limited | Medical devices and methods of making the same |
WO2005096988A1 (en) * | 2004-04-01 | 2005-10-20 | Cook Incorporated | A device for retracting the walls of a body vessel with remodelable material |
EP1600123A3 (en) * | 2004-05-26 | 2006-02-08 | Medtronic Vascular, Inc. | Semi-directional drug delivering stents |
WO2007100456A1 (en) * | 2006-03-01 | 2007-09-07 | Boston Scientific Scimed, Inc. | Flexible stent-graft devices and methods of producing the same |
US7737060B2 (en) * | 2006-03-31 | 2010-06-15 | Boston Scientific Scimed, Inc. | Medical devices containing multi-component fibers |
US7846199B2 (en) | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
US7854756B2 (en) | 2004-01-22 | 2010-12-21 | Boston Scientific Scimed, Inc. | Medical devices |
US8961588B2 (en) | 2002-03-27 | 2015-02-24 | Advanced Cardiovascular Systems, Inc. | Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin |
USRE45744E1 (en) | 2003-12-01 | 2015-10-13 | Abbott Cardiovascular Systems Inc. | Temperature controlled crimping |
US9205177B2 (en) | 2009-03-04 | 2015-12-08 | Peytant Solutions, Inc. | Stents modified with material comprising amnion tissue and corresponding processes |
EP3085334A1 (en) * | 2001-08-27 | 2016-10-26 | Boston Scientific Scimed, Inc. | Satiation devices |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023032084A1 (en) * | 2021-09-01 | 2023-03-09 | オリンパス株式会社 | Stent device and stent delivery system |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997009006A1 (en) * | 1995-09-01 | 1997-03-13 | Emory University | Endovascular support device and method of use |
US5693085A (en) * | 1994-04-29 | 1997-12-02 | Scimed Life Systems, Inc. | Stent with collagen |
WO1998023228A1 (en) * | 1996-11-25 | 1998-06-04 | Alza Corporation | Directional drug delivery stent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5334201A (en) * | 1993-03-12 | 1994-08-02 | Cowan Kevin P | Permanent stent made of a cross linkable material |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
EP1520557A3 (en) * | 1994-06-08 | 2010-07-21 | Cardiovascular Concepts, Inc. | Apparatus and methods for endoluminal graft placement |
EP1582181A3 (en) * | 1994-06-27 | 2010-04-21 | Bard Peripheral Vascular, Inc. | Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith |
-
1999
- 1999-12-23 GB GB9930534A patent/GB2346559A/en not_active Withdrawn
- 1999-12-23 WO PCT/GB1999/004388 patent/WO2000038590A1/en active Application Filing
- 1999-12-23 AU AU18790/00A patent/AU1879000A/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693085A (en) * | 1994-04-29 | 1997-12-02 | Scimed Life Systems, Inc. | Stent with collagen |
WO1997009006A1 (en) * | 1995-09-01 | 1997-03-13 | Emory University | Endovascular support device and method of use |
WO1998023228A1 (en) * | 1996-11-25 | 1998-06-04 | Alza Corporation | Directional drug delivery stent |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001021102A1 (en) * | 1999-09-23 | 2001-03-29 | Edwards Lifesciences Corporation | Double layer intraluminal graft |
US6503556B2 (en) | 2000-12-28 | 2003-01-07 | Advanced Cardiovascular Systems, Inc. | Methods of forming a coating for a prosthesis |
US6540776B2 (en) | 2000-12-28 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Sheath for a prosthesis and methods of forming the same |
WO2002091956A1 (en) * | 2001-05-16 | 2002-11-21 | Dias Maues, Christiane | Stent comprising a drug release coating thereon and delivering system thereof |
WO2002100473A1 (en) * | 2001-06-08 | 2002-12-19 | Graeme Cocks | Stent and delivery catheter |
EP1275405B1 (en) * | 2001-07-13 | 2006-10-11 | JOTEC GmbH | Implant with porous protein matrix and process for its production |
DE10135275A1 (en) * | 2001-07-13 | 2003-01-30 | Jotec Gmbh | Implant and process for its manufacture |
US7175852B2 (en) | 2001-07-13 | 2007-02-13 | Jotec Gmbh | Implant and process for producing it |
US9788984B2 (en) | 2001-08-27 | 2017-10-17 | Boston Scientific Scimed, Inc. | Satiation devices and methods |
EP3085334A1 (en) * | 2001-08-27 | 2016-10-26 | Boston Scientific Scimed, Inc. | Satiation devices |
US8961588B2 (en) | 2002-03-27 | 2015-02-24 | Advanced Cardiovascular Systems, Inc. | Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin |
WO2003090810A1 (en) * | 2002-04-26 | 2003-11-06 | Medtronic Vascular, Inc. | Overlapping coated stents |
US7771464B2 (en) | 2002-04-26 | 2010-08-10 | Medtronic Vascular, Inc. | Overlapping coated stents method |
US7993391B2 (en) | 2002-08-28 | 2011-08-09 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US7029495B2 (en) | 2002-08-28 | 2006-04-18 | Scimed Life Systems, Inc. | Medical devices and methods of making the same |
WO2004019821A1 (en) * | 2002-08-28 | 2004-03-11 | Boston Scientific Limited | Medical devices and methods of making the same |
USRE45744E1 (en) | 2003-12-01 | 2015-10-13 | Abbott Cardiovascular Systems Inc. | Temperature controlled crimping |
US7854756B2 (en) | 2004-01-22 | 2010-12-21 | Boston Scientific Scimed, Inc. | Medical devices |
US8048143B2 (en) | 2004-01-22 | 2011-11-01 | Boston Scientific Scimed, Inc. | Medical devices |
US8216299B2 (en) | 2004-04-01 | 2012-07-10 | Cook Medical Technologies Llc | Method to retract a body vessel wall with remodelable material |
WO2005096988A1 (en) * | 2004-04-01 | 2005-10-20 | Cook Incorporated | A device for retracting the walls of a body vessel with remodelable material |
EP1600123A3 (en) * | 2004-05-26 | 2006-02-08 | Medtronic Vascular, Inc. | Semi-directional drug delivering stents |
WO2007100456A1 (en) * | 2006-03-01 | 2007-09-07 | Boston Scientific Scimed, Inc. | Flexible stent-graft devices and methods of producing the same |
US7737060B2 (en) * | 2006-03-31 | 2010-06-15 | Boston Scientific Scimed, Inc. | Medical devices containing multi-component fibers |
US7846199B2 (en) | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
US9205177B2 (en) | 2009-03-04 | 2015-12-08 | Peytant Solutions, Inc. | Stents modified with material comprising amnion tissue and corresponding processes |
Also Published As
Publication number | Publication date |
---|---|
GB9930534D0 (en) | 2000-02-16 |
GB2346559A (en) | 2000-08-16 |
AU1879000A (en) | 2000-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000038590A1 (en) | Endoluminal stent | |
JP3231607B2 (en) | Polymer films for winding on stent structures | |
CA2304495C (en) | Non-thrombogenic stent jacket | |
US6117166A (en) | Apparatus and methods for grafting blood vessel tissue | |
US6214040B1 (en) | Sandwich stent with spiraling bands on an outer surface | |
US7550003B2 (en) | Conformal laminate stent device | |
JP2002540854A (en) | Pipe lining | |
JP3973692B2 (en) | Aggregates for intraluminal insertion of tubular stents and endovascular grafting devices | |
EP1067883A1 (en) | An implant comprising a support structure and a transition material made of porous plastics material | |
WO1997009006A1 (en) | Endovascular support device and method of use | |
JPH0747134A (en) | Stent and implant for lumen | |
JP2003514578A (en) | Spider silk covered stent | |
US7556643B2 (en) | Graft inside stent | |
CA2584714A1 (en) | Covered stent with controlled therapeutic agent diffusion | |
US20060246210A1 (en) | Method for making a covered drug-eluting stent | |
WO2000033768A1 (en) | Stent cover | |
US11925571B2 (en) | Stent device with stent covering with regions of differing porosity | |
AU780149B2 (en) | Non-thrombogenic stent jacket | |
WO1999015104A1 (en) | Non-thrombogenic stent jacket | |
EP1079767A1 (en) | Expandable space frame | |
EP1135081A1 (en) | Stent cover |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |